Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Injectional verapamil vs saline (short‐term) Quality of life · men with Peyronie's disease (palpable plaque or pain) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Injectional verapamil vs saline (short‐term) Discontinuation from treatment · men with Peyronie's disease (palpable plaque or pain) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Injectional Botox vs placebo Outcomes ( · men with Peyronie's disease (stable phase) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Injectional Botox vs placebo Patient‐reported ability to have intercourse · men with Peyronie's disease (stable phase) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Injectional Botox vs placebo Treatment‐related adverse effects · men with Peyronie's disease (stable phase) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Injectional Botox vs placebo Degree of penile curvature · men with Peyronie's disease (stable phase) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Injectional Botox vs placebo Discontinuation from treatment · men with Peyronie's disease (stable phase) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Extracorporeal shock wave treatment (ESWT) vs sham Outcomes ( · men with Peyronie's disease (penile plaque with pain and/or curvature, diagnosis of disease: from acute (< 12 months)… Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Potassium paraaminobenzoate vs placebo Degree of penile curvature · men with acute (maximum of 12 months) Peyronie's disease with no prior treatment and no evidence of calcified plaques… Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Penile traction therapy vs no treatment (short‐term) Outcomes ( · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Penile traction therapy vs no treatment (short‐term) Patient‐reported ability to have intercourse · men with Peyronie's disease (diagnosis of disease: varying, penile curvature: at least 30 degrees) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Injectional interferon alpha‐2B vs saline Outcomes ( · men with chronic (≥ 12 months) Peyronie's disease (single plaque) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Injectional interferon alpha‐2B vs saline Patient‐reported ability to have intercourse · men with chronic (≥ 12 months) Peyronie's disease (single plaque) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Injectional interferon alpha‐2B vs saline Quality of life · men with chronic (≥ 12 months) Peyronie's disease (single plaque) Non‐surgical therapies for Peyronie's disease (2023) · Cochrane | no estimate extracted | NR | No studies |
Lysine hyaluronate vs sodium hyaluronate Health‐related quality of life ‐ not reported · people with pressure ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Lysine hyaluronate vs sodium hyaluronate Pain · people with pressure ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs lyophilised collagen Adverse events ‐ not reported · foot ulcers in people with diabetes Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs lyophilised collagen Health‐related quality of life ‐ not reported · foot ulcers in people with diabetes Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs lyophilised collagen Change in ulcer size · foot ulcers in people with diabetes Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Platelet‐rich growth factor + hyaluronic acid vs platelet‐rich growth factor Time to complete wound healing ‐ not reported · pressure ulcer Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs conventional dressing (sterile petrolatum gauze) Time to complete wound healing ‐ not reported · foot ulcers in people with diabetes Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs conventional dressing (sterile petrolatum gauze) Health‐related quality of life ‐ not reported · foot ulcers in people with diabetes Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs conventional dressing (sterile petrolatum gauze) Pain · foot ulcers in people with diabetes Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid + hydrocolloid vs hydrocolloid Time to complete wound healing ‐ not reported · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid + hydrocolloid vs hydrocolloid Health‐related quality of life ‐ not reported · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs hydrocolloid Time to complete wound healing ‐ not reported · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs hydrocolloid Health‐related quality of life ‐ not reported · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs hydrocolloid Pain · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs paraffin gauze Time to complete wound healing ‐ not reported · leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs paraffin gauze Adverse events ‐ not reported · leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Platelet‐rich growth factor + hyaluronic acid vs platelet‐rich growth factor Health‐related quality of life · pressure ulcer Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs paraffin gauze Health‐related quality of life ‐ not reported · leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs paraffin gauze Pain · leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs neutral vehicle Health‐related quality of life ‐ not reported · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs dextranomer Complete ulcer healing ‐ not reported · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Platelet‐rich growth factor + hyaluronic acid vs platelet‐rich growth factor Pain · pressure ulcer Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs dextranomer Time to complete wound healing ‐ not reported · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs dextranomer Health‐related quality of life ‐ not reported · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Hyaluronic acid vs dextranomer Pain · people with leg ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Lysine hyaluronate vs sodium hyaluronate Time to complete wound healing ‐ not reported · people with pressure ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Lysine hyaluronate vs sodium hyaluronate Adverse events ‐ not reported · people with pressure ulcers Dressings and topical agents containing hyaluronic acid for chronic wound healing (2023) · Cochrane | no estimate extracted | NR | No studies |
Iridotomy vs no iridotomy Proportion of progressive visual field loss at 1 year · people with primary angle‐closure suspect Iridotomy to slow progression of visual field loss in angle‐closure glaucoma (2023) · Cochrane | no estimate extracted | NR | No studies |
Iridotomy vs no iridotomy Medications: mean number of medications used to control IOP at 1 year · people with primary angle‐closure suspect Iridotomy to slow progression of visual field loss in angle‐closure glaucoma (2023) · Cochrane | no estimate extracted | NR | No studies |
Iridotomy vs no iridotomy Quality of life measures · people with primary angle‐closure suspect Iridotomy to slow progression of visual field loss in angle‐closure glaucoma (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: Comparison 2 ‐ deferasirox (DFX) vs deferiprone (DFO) Sustained adherence Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or… (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: Comparison 2 ‐ deferasirox (DFX) vs deferiprone (DFO) QoL Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or… (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: Comparison 3 ‐ deferiprone (DFP) vs deferasirox (DFX) Sustained adherence Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or… (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: Comparison 3 ‐ deferiprone (DFP) vs deferasirox (DFX) QoL Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or… (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: Comparison 4 ‐ deferasirox (DFX) film‐coated tablets vs DFX dispersible tablets QoL Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or… (2023) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings: Comparison 5 ‐ deferiprone (DFP) plus deferoxamine (DFO) vs DFP Sustained adherence Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or… (2023) · Cochrane | no estimate extracted | NR | No studies |